|Day Low/High||4.40 / 4.60|
|52 Wk Low/High||2.93 / 4.62|
Codexis to Research and Develop Novel Enzymes Supporting Tate & Lyle's Food Ingredient Growth Strategies
Enzyme developed with CodeEvolver® technology for preclinical therapeutics program exceeds agreement requirements
Codexis, Inc. (Nasdaq: CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces the filing of a lawsuit against EnzymeWorks and its founder, Junhua "Alex" Tao, for willful...